Telbivudine monotherapy for HIV-HBV coinfected patients: an open explorative study.
Phase 4
Withdrawn
- Conditions
- hepatitis Bjaundice10047438
- Registration Number
- NL-OMON32543
- Lead Sponsor
- niversitair Medisch Centrum Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 35
Inclusion Criteria
HIV infected no HAART and HBV infected needing treatment
Exclusion Criteria
HAART indicated
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method